RU2125427C1 - Средство для лечения глазных заболеваний - оковидит - Google Patents

Средство для лечения глазных заболеваний - оковидит Download PDF

Info

Publication number
RU2125427C1
RU2125427C1 RU98110113A RU98110113A RU2125427C1 RU 2125427 C1 RU2125427 C1 RU 2125427C1 RU 98110113 A RU98110113 A RU 98110113A RU 98110113 A RU98110113 A RU 98110113A RU 2125427 C1 RU2125427 C1 RU 2125427C1
Authority
RU
Russia
Prior art keywords
treatment
eye
extract
visual acuity
polyethylene glycol
Prior art date
Application number
RU98110113A
Other languages
English (en)
Russian (ru)
Other versions
RU98110113A (ru
Inventor
Э.М. Миронова
Е.В. Гришин
Original Assignee
Миронова Эмилия Михайловна
Гришин Евгений Васильевич
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Миронова Эмилия Михайловна, Гришин Евгений Васильевич filed Critical Миронова Эмилия Михайловна
Priority to RU98110113A priority Critical patent/RU2125427C1/ru
Application granted granted Critical
Publication of RU2125427C1 publication Critical patent/RU2125427C1/ru
Publication of RU98110113A publication Critical patent/RU98110113A/ru
Priority to PCT/RU1999/000172 priority patent/WO1999060948A2/fr
Priority to AU41750/99A priority patent/AU4175099A/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
RU98110113A 1998-05-27 1998-05-27 Средство для лечения глазных заболеваний - оковидит RU2125427C1 (ru)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU98110113A RU2125427C1 (ru) 1998-05-27 1998-05-27 Средство для лечения глазных заболеваний - оковидит
PCT/RU1999/000172 WO1999060948A2 (fr) 1998-05-27 1999-05-25 Principe permettant de traiter des maladies oculaires
AU41750/99A AU4175099A (en) 1998-05-27 1999-05-25 Medium for treating eye diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98110113A RU2125427C1 (ru) 1998-05-27 1998-05-27 Средство для лечения глазных заболеваний - оковидит

Publications (2)

Publication Number Publication Date
RU2125427C1 true RU2125427C1 (ru) 1999-01-27
RU98110113A RU98110113A (ru) 1999-05-10

Family

ID=20206511

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98110113A RU2125427C1 (ru) 1998-05-27 1998-05-27 Средство для лечения глазных заболеваний - оковидит

Country Status (3)

Country Link
AU (1) AU4175099A (fr)
RU (1) RU2125427C1 (fr)
WO (1) WO1999060948A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060036220A1 (en) * 2003-01-22 2006-02-16 Kohji Kawahara Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
EP1901724A1 (fr) * 2005-07-08 2008-03-26 Senju Pharmaceutical Co., Ltd. Préparation ophtalmique à absorption percutanée comprenant de l'épinastine
MX2009012879A (es) * 2007-07-20 2010-01-14 Alcon Inc Formulacion farmaceutica para suministrar a los ojos compuestos que inhiben el receptor tirosina cinasa (rtki).

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2242991A1 (en) * 1973-09-12 1975-04-04 Prat Andre Liq. marine algal extracts - used in pharmacological, therapeutic or cosmetic compsns
FR2513121A1 (fr) * 1981-09-23 1983-03-25 Goemar Sa Nouveaux medicaments, produits cosmetiques et produits dietetiques a base d'extraits d'algues, et formulations correspondantes
ATE132366T1 (de) * 1990-05-29 1996-01-15 Boston Ocular Res Zusammensetzung zur behandlung von dry eye erkrankungen
RU2019186C1 (ru) * 1991-02-28 1994-09-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи Способ ингибиции вич-инфекции
RU2005485C1 (ru) * 1991-04-12 1994-01-15 Станислав Григорьевич Батраков Способ получения средства для лечения заболеваний кожи у животных
RU2062079C1 (ru) * 1993-08-25 1996-06-20 Уфимский научно-исследовательский институт глазных болезней Глазные капли

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Горбань А.И. и др. Микрохирургия глаза, ошибки и осложнения - С.-Петербург, 1993, с.243. *

Also Published As

Publication number Publication date
WO1999060948A3 (fr) 2000-02-10
WO1999060948A2 (fr) 1999-12-02
AU4175099A (en) 1999-12-13

Similar Documents

Publication Publication Date Title
KR101433152B1 (ko) 안과용 약물의 전달에 유용한 젤
JP5583310B2 (ja) 眼球の症状の予防及び治療のための眼科用製剤
US5366739A (en) Method of ophthalmic drug delivery
JPH0216728B2 (fr)
EA013931B1 (ru) Способ лечения глазных расстройств
MX2012009471A (es) Composicion que comprende como ingrediente activo l-carnitina en combinacion con hidroxiquinurenina-o-beta-dl-glucosido, para la prevencion y/o tratamiento de patologias del ojo debido a radiacion ultravioleta.
JPH0723325B2 (ja) 眼病用製剤
RU2530629C2 (ru) Вызываемая медикаментозными средствами липоатрофия для косметических целей
RU2125427C1 (ru) Средство для лечения глазных заболеваний - оковидит
DE3330053A1 (de) Retinoprotektor zur behandlung von inneren augenblutungen, myopischen, chorioretinalen dystrophien, erblichen netzhautdystrophien, -verbrennungen und zur vorbeugung vor verletzungen bei laserkoagulation
WO2023225551A1 (fr) Nouvelles applications de zwitterions dans des compositions et des préparations de crème topique ophtalmique
JPH0381220A (ja) 眼病用製薬組成物
Swan Pharmacology and Toxicology of the Cornea: Contemporary Concepts
Okinami et al. Acute Severe Uveitis with Retinal Vasculitis and Retinal Detachment I. With 1 Colour Plate
KR20230170963A (ko) 근시 치료용 방법과 약학 조성물
CN111450054B (zh) 一种含有咖啡酸酯的眼用制剂、制备方法及应用
RU2104679C1 (ru) Офтальмологическое лекарственное средство
CN105726698B (zh) 一种缓解视疲劳的玫瑰组合物、眼贴及其制备方法
RU2070010C1 (ru) Средство антиоксидантной защиты сред и тканей глаза
AU2020352751B2 (en) Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
CN100508987C (zh) 玻璃酸在制备用于预防或改善眼玻璃体变性疾病的口服产品中的应用
RU2716429C1 (ru) Способ лечения рецидивирующей эрозии роговицы различного генеза
CN102210684A (zh) 四氢嘧啶及其衍生物在制备治疗白内障药物中的应用
CN117547550A (zh) 一种预防和治疗白内障的药物及其制备方法
KR20110025824A (ko) 조절성 눈피로의 예방 또는 치료용 화합물